0000-00-00 |
1 |
|
of U.S. Patent No.
9,820,959 (“the ’959 Patent”), U.S. Patent No. 9,833,428 (“the ’428 Patent”), and …and U.S. Patent
No. 9,833,429 (“the ’429 Patent”) (collectively, “the Patents-in-Suit”).
14. …Related LEO Patents and other U.S. patents owned by LEO, and Perrigo contends
that such patents are unenforceable…infringe
on such patents.
38. The Patents-in-Suit are continuations of patents among the Related… This is a civil action for patent infringement arising under the patent laws of the
United States, |
External link to document |
0000-00-00 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,820,959 B2; 9,833,428 B2; 9,833,429…2017
9 April 2018
1:17-cv-01753
835 Patent - Abbreviated New Drug Application(ANDA)
|
External link to document |
2018-02-21 |
44 |
|
Supplemental Infringement Charts for U.S. Patent Nos. 8,278,292; 9,820,959; 9,833,428; and 9,833,429; (10…Plaintiffs' Supplemental Infringement Charts for U.S. Patent Nos. 9,416,084 and 9,676,698; (12) Plaintiffs' …2017
9 April 2018
1:17-cv-01753
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2018-03-12 |
57 |
|
Initial Invalidity Contentions Regarding U.S. Patent Nos. 9,820,959, 9,833,428 and 9,833,429 filed by Perrigo…2017
9 April 2018
1:17-cv-01753
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2018-04-09 |
72 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,820,959 B2; 9,833,428 B2; 9,833,429…2017
9 April 2018
1:17-cv-01753
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |